{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T13:45:02Z","timestamp":1776606302826,"version":"3.51.2"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,19]]},"DOI":"10.7759\/cureus.107337","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T13:10:20Z","timestamp":1776604220000},"source":"Crossref","is-referenced-by-count":0,"title":["Top 50 Cited Articles on the Treatment of Major Depressive Disorder"],"prefix":"10.7759","author":[{"given":"Ahmed A","family":"Albesher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayef A","family":"Muflehi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazan A","family":"Hakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana A","family":"Barnawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randah E","family":"Softah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luluwah H","family":"Al Ghalib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayar A","family":"Bukhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reem A","family":"Almotiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha S","family":"Algethami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahad W","family":"Mahboob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Relam K","family":"Hakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Alsaad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","article-title":"","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Publishing, Arlington, VA; 2013. 10.1176\/appi.books.9780890425596"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291712001511","article-title":"Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature","volume":"43","author":"Ferrari AJ","year":"2013","unstructured":"Ferrari AJ, Somerville AJ, Baxter AJ, Norman R, Patten SB, Vos T, Whiteford HA. Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med. 2013, 43:471-81. 10.1017\/S0033291712001511","journal-title":"Psychol Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"9","author":"GBD 2019 Mental Disorders Collaborators","year":"2022","unstructured":"GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022, 9:137-50. 10.1016\/S2215-0366(21)00395-3","journal-title":"Lancet Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler RC","year":"2005","unstructured":"Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005, 62:593-602. 10.1001\/archpsyc.62.6.593","journal-title":"Arch Gen Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20038","article-title":"The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons","volume":"12","author":"Cuijpers P","year":"2013","unstructured":"Cuijpers P, Sijbrandij M, Koole SL, Andersson G, Beekman AT, Reynolds CF 3rd. The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons. World Psychiatry. 2013, 12:137-48. 10.1002\/wps.20038","journal-title":"World Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-014912","article-title":"Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews","volume":"7","author":"Gartlehner G","year":"2017","unstructured":"Gartlehner G, Wagner G, Matyas N, et al.. Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews. BMJ Open. 2017, 7:e014912. 10.1136\/bmjopen-2016-014912","journal-title":"BMJ Open"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S29716","article-title":"Treatment-resistant depression: therapeutic trends, challenges, and future directions","volume":"6","author":"Al-Harbi KS","year":"2012","unstructured":"Al-Harbi KS. Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Prefer Adherence. 2012, 6:369-88. 10.2147\/PPA.S29716","journal-title":"Patient Prefer Adherence"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S198774","article-title":"Management of treatment-resistant depression: challenges and strategies","volume":"16","author":"Voineskos D","year":"2020","unstructured":"Voineskos D, Daskalakis ZJ, Blumberger DM. Management of treatment-resistant depression: challenges and strategies. Neuropsychiatr Dis Treat. 2020, 16:221-34. 10.2147\/NDT.S198774","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h6019","article-title":"Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis","volume":"351","author":"Amick HR","year":"2015","unstructured":"Amick HR, Gartlehner G, Gaynes BN, et al.. Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis. BMJ. 2015, 351:h6019. 10.1136\/bmj.h6019","journal-title":"BMJ"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani A","year":"2018","unstructured":"Cipriani A, Furukawa TA, Salanti G, et al.. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018, 391:1357-66. 10.1016\/S0140-6736(17)32802-7","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2011.05.002","article-title":"The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: a systematic review and meta-analysis","volume":"31","author":"Piet J","year":"2011","unstructured":"Piet J, Hougaard E. The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: a systematic review and meta-analysis. Clin Psychol Rev. 2011, 31:1032-40. 10.1016\/j.cpr.2011.05.002","journal-title":"Clin Psychol Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00647","article-title":"Research on the development of theme trends and changes of knowledge structures of drug therapy studies on major depressive disorder since the 21(st) century: a bibliometric analysis","volume":"11","author":"Duan L","year":"2020","unstructured":"Duan L, Gao Y, Shao X, Tian C, Fu C, Zhu G. Research on the development of theme trends and changes of knowledge structures of drug therapy studies on major depressive disorder since the 21(st) century: a bibliometric analysis. Front Psychiatry. 2020, 11:647. 10.3389\/fpsyt.2020.00647","journal-title":"Front Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e33833","article-title":"Twenty-five years of research on resting-state fMRI of major depressive disorder: a bibliometric analysis of hotspots, nodes, bursts, and trends","volume":"10","author":"Fu L","year":"2024","unstructured":"Fu L, Cai M, Zhao Y, et al.. Twenty-five years of research on resting-state fMRI of major depressive disorder: a bibliometric analysis of hotspots, nodes, bursts, and trends. Heliyon. 2024, 10:e33833. 10.1016\/j.heliyon.2024.e33833","journal-title":"Heliyon"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2010.08.006","article-title":"Global trends and performances of acupuncture research","volume":"35","author":"Han JS","year":"2011","unstructured":"Han JS, Ho YS. Global trends and performances of acupuncture research. Neurosci Biobehav Rev. 2011, 35:680-7. 10.1016\/j.neubiorev.2010.08.006","journal-title":"Neurosci Biobehav Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5498\/wjp.v15.i4.104600","article-title":"Comprehensive bibliometric analysis of transcranial magnetic stimulation-based depression treatment from 2003 to 2022: research hotspots and trends","volume":"15","author":"Li ZY","year":"2025","unstructured":"Li ZY, Zhang YW, Yang HR, et al.. Comprehensive bibliometric analysis of transcranial magnetic stimulation-based depression treatment from 2003 to 2022: research hotspots and trends. World J Psychiatry. 2025, 15:104600. 10.5498\/wjp.v15.i4.104600","journal-title":"World J Psychiatry"},{"key":"ref16","unstructured":"Oxford Centre for Evidence-Based Medicine. levels of evidence (March 2009). https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/oxford-centre-for-evidence-based-medicine-levels-of-evidence-m...."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.22.2836","article-title":"Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial","volume":"288","author":"Un\u00fctzer J","year":"2002","unstructured":"Un\u00fctzer J, Katon W, Callahan CM, et al.. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA. 2002, 288:2836-45. 10.1001\/jama.288.22.2836","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1989.01810110013002","article-title":"National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments","volume":"46","author":"Elkin I","year":"1989","unstructured":"Elkin I, Shea MT, Watkins JT, et al.. National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Arch Gen Psychiatry. 1989, 46:971-82; discussion 983. 10.1001\/archpsyc.1989.01810110013002","journal-title":"Arch Gen Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/0706743716659417","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments","volume":"61","author":"Kennedy SH","year":"2016","unstructured":"Kennedy SH, Lam RW, McIntyre RS, et al.. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments. Can J Psychiatry. 2016, 61:540-60. 10.1177\/0706743716659417","journal-title":"Can J Psychiatry"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1996.01830100072009","article-title":"A multifaceted intervention to improve treatment of depression in primary care","volume":"53","author":"Katon W","year":"1996","unstructured":"Katon W, Robinson P, Von Korff M, et al.. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry. 1996, 53:924-32. 10.1001\/archpsyc.1996.01830100072009","journal-title":"Arch Gen Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0791-y","article-title":"A randomised controlled trial of dietary improvement for adults with major depression (the 'SMILES' trial)","volume":"15","author":"Jacka FN","year":"2017","unstructured":"Jacka FN, O'Neil A, Opie R, et al.. A randomised controlled trial of dietary improvement for adults with major depression (the 'SMILES' trial). BMC Med. 2017, 15:23. 10.1186\/s12916-017-0791-y","journal-title":"BMC Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.4.367","article-title":"Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial","volume":"297","author":"Lesp\u00e9rance F","year":"2007","unstructured":"Lesp\u00e9rance F, Frasure-Smith N, Koszycki D, et al.. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA. 2007, 297:367-79. 10.1001\/jama.297.4.367","journal-title":"JAMA"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1176\/foc.4.2.278","article-title":"Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program","volume":"148","author":"Sotsky SM","year":"1991","unstructured":"Sotsky SM, Glass DR, Shea MT, et al.. Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry. 1991, 148:997-1008. 10.1176\/foc.4.2.278","journal-title":"Am J Psychiatry"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1992.01820100026006","article-title":"Course of depressive symptoms over follow-up. Findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program","volume":"49","author":"Shea MT","year":"1992","unstructured":"Shea MT, Elkin I, Imber SD, et al.. Course of depressive symptoms over follow-up. Findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Arch Gen Psychiatry. 1992, 49:782-7. 10.1001\/archpsyc.1992.01820100026006","journal-title":"Arch Gen Psychiatry"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1177\/0706743716660033","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 4. Neurostimulation treatments","volume":"61","author":"Milev RV","year":"2016","unstructured":"Milev RV, Giacobbe P, Kennedy SH, et al.. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 4. Neurostimulation treatments. Can J Psychiatry. 2016, 61:561-75. 10.1177\/0706743716660033","journal-title":"Can J Psychiatry"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.55.9.816","article-title":"Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings","volume":"55","author":"Fava GA","year":"1998","unstructured":"Fava GA, Rafanelli C, Grandi S, Conti S, Belluardo P. Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings. Arch Gen Psychiatry. 1998, 55:816-20. 10.1001\/archpsyc.55.9.816","journal-title":"Arch Gen Psychiatry"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2009.06.041","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy","volume":"117 Suppl 1","author":"Lam RW","year":"2009","unstructured":"Lam RW, Kennedy SH, Grigoriadis S, et al.. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. J Affect Disord. 2009, 117 Suppl 1:S26-43. 10.1016\/j.jad.2009.06.041","journal-title":"J Affect Disord"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2850.2009.01178.x","article-title":"Behavioral activation treatments for depression in adults: a meta-analysis and review","volume":"16","author":"Mazzucchelli T","year":"2009","unstructured":"Mazzucchelli T, Kane R, Rees C. Behavioral activation treatments for depression in adults: a meta-analysis and review. Clin Psychol (New York). 2009, 16:383-411. 10.1111\/j.1468-2850.2009.01178.x","journal-title":"Clin Psychol (New York)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7226.26","article-title":"Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care","volume":"320","author":"Mynors-Wallis LM","year":"2000","unstructured":"Mynors-Wallis LM, Gath DH, Day A, Baker F. Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care. BMJ. 2000, 320:26-30. 10.1136\/bmj.320.7226.26","journal-title":"BMJ"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2010.168","article-title":"Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression","volume":"67","author":"Segal ZV","year":"2010","unstructured":"Segal ZV, Bieling P, Young T, et al.. Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression. Arch Gen Psychiatry. 2010, 67:1256-64. 10.1001\/archgenpsychiatry.2010.168","journal-title":"Arch Gen Psychiatry"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.07m03780","article-title":"Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients","volume":"70","author":"Szegedi A","year":"2009","unstructured":"Szegedi A, Jansen WT, van Willigenburg AP, van der Meulen E, Stassen HH, Thase ME. Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. J Clin Psychiatry. 2009, 70:344-53. 10.4088\/jcp.07m03780","journal-title":"J Clin Psychiatry"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-11-201112060-00009","article-title":"Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis","volume":"155","author":"Gartlehner G","year":"2011","unstructured":"Gartlehner G, Hansen RA, Morgan LC, et al.. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Ann Intern Med. 2011, 155:772-85. 10.7326\/0003-4819-155-11-201112060-00009","journal-title":"Ann Intern Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.63.5.841","article-title":"Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program","volume":"63","author":"Elkin I","year":"1995","unstructured":"Elkin I, Gibbons RD, Shea MT, Sotsky SM, Watkins JT, Pilkonis PA, Hedeker D. Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Consult Clin Psychol. 1995, 63:841-7. 10.1037\/0022-006X.63.5.841","journal-title":"J Consult Clin Psychol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.61.7.669","article-title":"Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project","volume":"61","author":"Trivedi MH","year":"2004","unstructured":"Trivedi MH, Rush AJ, Crismon ML, et al.. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Arch Gen Psychiatry. 2004, 61:669-80. 10.1001\/archpsyc.61.7.669","journal-title":"Arch Gen Psychiatry"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2010.03.011","article-title":"Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis","volume":"32","author":"van der Feltz-Cornelis CM","year":"2010","unstructured":"van der Feltz-Cornelis CM, Nuyen J, Stoop C, et al.. Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis. Gen Hosp Psychiatry. 2010, 32:380-95. 10.1016\/j.genhosppsych.2010.03.011","journal-title":"Gen Hosp Psychiatry"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60991-5","article-title":"Management of depression for people with cancer 4 (SMaRT oncology 1): a randomised trial","volume":"372","author":"Strong V","year":"2008","unstructured":"Strong V, Waters R, Hibberd C, et al.. Management of depression for people with cancer 4 (SMaRT oncology 1): a randomised trial. Lancet. 2008, 372:40-8. 10.1016\/S0140-6736(08)60991-5","journal-title":"Lancet"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1177\/0706743716659418","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 2. Psychological treatments","volume":"61","author":"Parikh SV","year":"2016","unstructured":"Parikh SV, Quilty LC, Ravitz P, et al.. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 2. Psychological treatments. Can J Psychiatry. 2016, 61:524-39. 10.1177\/0706743716659418","journal-title":"Can J Psychiatry"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1177\/0706743716660290","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 5. Complementary and alternative medicine treatments","volume":"61","author":"Ravindran AV","year":"2016","unstructured":"Ravindran AV, Balneaves LG, Faulkner G, et al.. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 5. Complementary and alternative medicine treatments. Can J Psychiatry. 2016, 61:576-87. 10.1177\/0706743716660290","journal-title":"Can J Psychiatry"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-200108000-00005","article-title":"Improving primary care for depression in late life: the design of a multicenter randomized trial","volume":"39","author":"Un\u00fctzer J","year":"2001","unstructured":"Un\u00fctzer J, Katon W, Williams JW Jr, et al.. Improving primary care for depression in late life: the design of a multicenter randomized trial. Med Care. 2001, 39:785-99. 10.1097\/00005650-200108000-00005","journal-title":"Med Care"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1017\/s1092852900020216","article-title":"Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants","volume":"14","author":"Berman RM","year":"2009","unstructured":"Berman RM, Fava M, Thase ME, et al.. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants. CNS Spectr. 2009, 14:197-206. 10.1017\/s1092852900020216","journal-title":"CNS Spectr"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.9.1007","article-title":"Telephone-administered psychotherapy for depression","volume":"62","author":"Mohr DC","year":"2005","unstructured":"Mohr DC, Hart SL, Julian L, Catledge C, Honos-Webb L, Vella L, Tasch ET. Telephone-administered psychotherapy for depression. Arch Gen Psychiatry. 2005, 62:1007-14. 10.1001\/archpsyc.62.9.1007","journal-title":"Arch Gen Psychiatry"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.6371","article-title":"Randomized controlled trial of collaborative care management of depression among low-income patients with cancer","volume":"26","author":"Ell K","year":"2008","unstructured":"Ell K, Xie B, Quon B, Quinn DI, Dwight-Johnson M, Lee PJ. Randomized controlled trial of collaborative care management of depression among low-income patients with cancer. J Clin Oncol. 2008, 26:4488-96. 10.1200\/JCO.2008.16.6371","journal-title":"J Clin Oncol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1177\/0706743716659276","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 6. Special populations: youth, women, and the elderly","volume":"61","author":"MacQueen GM","year":"2016","unstructured":"MacQueen GM, Frey BN, Ismail Z, et al.. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 6. Special populations: youth, women, and the elderly. Can J Psychiatry. 2016, 61:588-603. 10.1177\/0706743716659276","journal-title":"Can J Psychiatry"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2015.2235","article-title":"Efficacy of bright light treatment, fluoxetine, and the combination in patients with nonseasonal major depressive disorder: a randomized clinical trial","volume":"73","author":"Lam RW","year":"2016","unstructured":"Lam RW, Levitt AJ, Levitan RD, et al.. Efficacy of bright light treatment, fluoxetine, and the combination in patients with nonseasonal major depressive disorder: a randomized clinical trial. JAMA Psychiatry. 2016, 73:56-63. 10.1001\/jamapsychiatry.2015.2235","journal-title":"JAMA Psychiatry"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1177\/070674370805300909","article-title":"Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis","volume":"53","author":"Lam RW","year":"2008","unstructured":"Lam RW, Chan P, Wilkins-Ho M, Yatham LN. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis. Can J Psychiatry. 2008, 53:621-31. 10.1177\/070674370805300909","journal-title":"Can J Psychiatry"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1080\/13607860701529635","article-title":"Effects of psychotherapy and other behavioral interventions on clinically depressed older adults: a meta-analysis","volume":"11","author":"Pinquart M","year":"2007","unstructured":"Pinquart M, Duberstein PR, Lyness JM. Effects of psychotherapy and other behavioral interventions on clinically depressed older adults: a meta-analysis. Aging Ment Health. 2007, 11:645-57. 10.1080\/13607860701529635","journal-title":"Aging Ment Health"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2011.02.005","article-title":"Moderate exercise improves depression parameters in treatment-resistant patients with major depressive disorder","volume":"45","author":"Mota-Pereira J","year":"2011","unstructured":"Mota-Pereira J, Silverio J, Carvalho S, Ribeiro JC, Fonte D, Ramos J. Moderate exercise improves depression parameters in treatment-resistant patients with major depressive disorder. J Psychiatr Res. 2011, 45:1005-11. 10.1016\/j.jpsychires.2011.02.005","journal-title":"J Psychiatr Res"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2003.11109.x","article-title":"Effectiveness of collaborative care depression treatment in Veterans' Affairs primary care","volume":"18","author":"Hedrick SC","year":"2003","unstructured":"Hedrick SC, Chaney EF, Felker B, et al.. Effectiveness of collaborative care depression treatment in Veterans' Affairs primary care. J Gen Intern Med. 2003, 18:9-16. 10.1046\/j.1525-1497.2003.11109.x","journal-title":"J Gen Intern Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.10.1443","article-title":"Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression","volume":"155","author":"Fava GA","year":"1998","unstructured":"Fava GA, Rafanelli C, Grandi S, Canestrari R, Morphy MA. Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry. 1998, 155:1443-5. 10.1176\/ajp.155.10.1443","journal-title":"Am J Psychiatry"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e3283649b9a","article-title":"Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting","volume":"23","author":"Hall-Flavin DK","year":"2013","unstructured":"Hall-Flavin DK, Winner JG, Allen JD, et al.. Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting. Pharmacogenet Genomics. 2013, 23:535-48. 10.1097\/FPC.0b013e3283649b9a","journal-title":"Pharmacogenet Genomics"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1097\/CHI.0b013e3181a2b304","article-title":"Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial","volume":"48","author":"Emslie GJ","year":"2009","unstructured":"Emslie GJ, Ventura D, Korotzer A, Tourkodimitris S. Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial. J Am Acad Child Adolesc Psychiatry. 2009, 48:721-9. 10.1097\/CHI.0b013e3181a2b304","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.5211","article-title":"Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder","volume":"29","author":"Panahi Y","year":"2015","unstructured":"Panahi Y, Badeli R, Karami GR, Sahebkar A. Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder. Phytother Res. 2015, 29:17-21. 10.1002\/ptr.5211","journal-title":"Phytother Res"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2009.06.042","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication","volume":"117 Suppl 1","author":"Parikh SV","year":"2009","unstructured":"Parikh SV, Segal ZV, Grigoriadis S, Ravindran AV, Kennedy SH, Lam RW, Patten SB. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication. J Affect Disord. 2009, 117 Suppl 1:S15-25. 10.1016\/j.jad.2009.06.042","journal-title":"J Affect Disord"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-10-200811180-00007","article-title":"Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians","volume":"149","author":"Qaseem A","year":"2008","unstructured":"Qaseem A, Snow V, Denberg TD, Forciea MA, Owens DK. Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2008, 149:725-33. 10.7326\/0003-4819-149-10-200811180-00007","journal-title":"Ann Intern Med"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301390","article-title":"Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care","volume":"32","author":"Trivedi MH","year":"2007","unstructured":"Trivedi MH, Rush AJ, Gaynes BN, et al.. Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care. Neuropsychopharmacology. 2007, 32:2479-89. 10.1038\/sj.npp.1301390","journal-title":"Neuropsychopharmacology"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2012.04166.x","article-title":"Cognitive behavioral therapy for depression in older people: a meta-analysis and meta-regression of randomized controlled trials","volume":"60","author":"Gould RL","year":"2012","unstructured":"Gould RL, Coulson MC, Howard RJ. Cognitive behavioral therapy for depression in older people: a meta-analysis and meta-regression of randomized controlled trials. J Am Geriatr Soc. 2012, 60:1817-30. 10.1111\/j.1532-5415.2012.04166.x","journal-title":"J Am Geriatr Soc"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2009.06.039","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies","volume":"117 Suppl 1","author":"Kennedy SH","year":"2009","unstructured":"Kennedy SH, Milev R, Giacobbe P, et al.. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies. J Affect Disord. 2009, 117 Suppl 1:S44-53. 10.1016\/j.jad.2009.06.039","journal-title":"J Affect Disord"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3233\/RNN-170810","article-title":"Yoga- and meditation-based lifestyle intervention increases neuroplasticity and reduces severity of major depressive disorder: a randomized controlled trial","volume":"36","author":"Tolahunase MR","year":"2018","unstructured":"Tolahunase MR, Sagar R, Faiq M, Dada R. Yoga- and meditation-based lifestyle intervention increases neuroplasticity and reduces severity of major depressive disorder: a randomized controlled trial. Restor Neurol Neurosci. 2018, 36:423-42. 10.3233\/RNN-170810","journal-title":"Restor Neurol Neurosci"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.15040476","article-title":"The sequential integration of pharmacotherapy and psychotherapy in the treatment of major depressive disorder: a meta-analysis of the sequential model and a critical review of the literature","volume":"173","author":"Guidi J","year":"2016","unstructured":"Guidi J, Tomba E, Fava GA. The sequential integration of pharmacotherapy and psychotherapy in the treatment of major depressive disorder: a meta-analysis of the sequential model and a critical review of the literature. Am J Psychiatry. 2016, 173:128-37. 10.1176\/appi.ajp.2015.15040476","journal-title":"Am J Psychiatry"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2003.08.005","article-title":"The impact of a pharmacist intervention on 6-month outcomes in depressed primary care patients","volume":"26","author":"Adler DA","year":"2004","unstructured":"Adler DA, Bungay KM, Wilson IB, et al.. The impact of a pharmacist intervention on 6-month outcomes in depressed primary care patients. Gen Hosp Psychiatry. 2004, 26:199-209. 10.1016\/j.genhosppsych.2003.08.005","journal-title":"Gen Hosp Psychiatry"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajgp.13.10.884","article-title":"Escitalopram in the treatment of depressed elderly patients","volume":"13","author":"Kasper S","year":"2005","unstructured":"Kasper S, de Swart H, Friis Andersen H. Escitalopram in the treatment of depressed elderly patients. Am J Geriatr Psychiatry. 2005, 13:884-91. 10.1176\/appi.ajgp.13.10.884","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7080195","article-title":"Effects of meditative movements on major depressive disorder: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Zou L","year":"2018","unstructured":"Zou L, Yeung A, Li C, et al.. Effects of meditative movements on major depressive disorder: a systematic review and meta-analysis of randomized controlled trials. J Clin Med. 2018, 7:195. 10.3390\/jcm7080195","journal-title":"J Clin Med"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.171.2.131","article-title":"Acute and one-year outcome of a randomised controlled trial of brief cognitive therapy for major depressive disorder in primary care","volume":"171","author":"Scott C","year":"1997","unstructured":"Scott C, Tacchi MJ, Jones R, Scott J. Acute and one-year outcome of a randomised controlled trial of brief cognitive therapy for major depressive disorder in primary care. Br J Psychiatry. 1997, 171:131-4. 10.1192\/bjp.171.2.131","journal-title":"Br J Psychiatry"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000231","article-title":"Improving care for depression in obstetrics and gynecology: a randomized controlled trial","volume":"123","author":"Melville JL","year":"2014","unstructured":"Melville JL, Reed SD, Russo J, Croicu CA, Ludman E, LaRocco-Cockburn A, Katon W. Improving care for depression in obstetrics and gynecology: a randomized controlled trial. Obstet Gynecol. 2014, 123:1237-46. 10.1097\/AOG.0000000000000231","journal-title":"Obstet Gynecol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.164.5.768","article-title":"An intensive treatment program of interpersonal psychotherapy plus pharmacotherapy for depressed inpatients: acute and long-term results","volume":"164","author":"Schramm E","year":"2007","unstructured":"Schramm E, van Calker D, Dykierek P, et al.. An intensive treatment program of interpersonal psychotherapy plus pharmacotherapy for depressed inpatients: acute and long-term results. Am J Psychiatry. 2007, 164:768-77. 10.1176\/appi.ajp.164.5.768","journal-title":"Am J Psychiatry"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.29219\/fnr.v62.1218","article-title":"Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome: a randomised, double-blind, placebo controlled, multi-centre, pilot clinical study","volume":"62","author":"Majeed M","year":"2018","unstructured":"Majeed M, Nagabhushanam K, Arumugam S, Majeed S, Ali F. Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome: a randomised, double-blind, placebo controlled, multi-centre, pilot clinical study. Food Nutr Res. 2018, 62:10.29219\/fnr.v62.1218","journal-title":"Food Nutr Res"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush AJ","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, et al.. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006, 163:1905-17. 10.1176\/ajp.2006.163.11.1905","journal-title":"Am J Psychiatry"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough JW","year":"2013","unstructured":"Murrough JW, Iosifescu DV, Chang LC, et al.. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry. 2013, 170:1134-42. 10.1176\/appi.ajp.2013.13030392","journal-title":"Am J Psychiatry"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.13r08815","article-title":"Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis","volume":"75","author":"Gaynes BN","year":"2014","unstructured":"Gaynes BN, Lloyd SW, Lux L, et al.. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. J Clin Psychiatry. 2014, 75:477-89; quiz 489. 10.4088\/JCP.13r08815","journal-title":"J Clin Psychiatry"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1136125","article-title":"Systematic reviews and meta-analyses on major depressive disorder: a bibliometric perspective","volume":"14","author":"Chen P","year":"2023","unstructured":"Chen P, Feng Y, Li XH, et al.. Systematic reviews and meta-analyses on major depressive disorder: a bibliometric perspective. Front Psychiatry. 2023, 14:1136125. 10.3389\/fpsyt.2023.1136125","journal-title":"Front Psychiatry"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138237","article-title":"The role of Google Scholar in evidence reviews and its applicability to grey literature searching","volume":"10","author":"Haddaway NR","year":"2015","unstructured":"Haddaway NR, Collins AM, Coughlin D, Kirk S. The role of Google Scholar in evidence reviews and its applicability to grey literature searching. PLoS One. 2015, 10:e0138237. 10.1371\/journal.pone.0138237","journal-title":"PLoS One"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12010093","article-title":"The contribution of \"individual participant data\" meta-analyses of psychotherapies for depression to the development of personalized treatments: a systematic review","volume":"12","author":"Cuijpers P","year":"2022","unstructured":"Cuijpers P, Ciharova M, Quero S, et al.. The contribution of \"individual participant data\" meta-analyses of psychotherapies for depression to the development of personalized treatments: a systematic review. J Pers Med. 2022, 12:93. 10.3390\/jpm12010093","journal-title":"J Pers Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/469848-top-50-cited-articles-on-the-treatment-of-major-depressive-disorder","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T13:10:22Z","timestamp":1776604222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/469848-top-50-cited-articles-on-the-treatment-of-major-depressive-disorder"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,19]]},"references-count":72,"URL":"https:\/\/doi.org\/10.7759\/cureus.107337","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,19]]}}}